Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Receivables - Net: 2019-2025

Historic Receivables - Net for Bicycle Therapeutics (BCYC) over the last 3 years, with Mar 2025 value amounting to $136,000.

  • Bicycle Therapeutics' Receivables - Net was N/A to $136,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $136,000, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2022, which is 104.50% up from last year.
  • According to the latest figures from Q1 2025, Bicycle Therapeutics' Receivables - Net is $136,000, which was down 41.63% from $233,000 recorded in Q2 2024.
  • Over the past 5 years, Bicycle Therapeutics' Receivables - Net peaked at $50.0 million during Q1 2023, and registered a low of $136,000 during Q1 2025.
  • Moreover, its 3-year median value for Receivables - Net was $22.7 million (2023), whereas its average is $23.9 million.
  • In the last 5 years, Bicycle Therapeutics' Receivables - Net surged by 2,073.91% in 2023 and then tumbled by 99.48% in 2024.
  • Bicycle Therapeutics' Receivables - Net (Quarterly) stood at $1.0 million in 2021, then spiked by 104.50% to $2.0 million in 2022, then spiked by 350.90% to $45.1 million in 2023, then crashed by 99.48% to $233,000 in 2024, then reached $136,000 in 2025.
  • Its Receivables - Net was $136,000 in Q1 2025, compared to $233,000 in Q2 2024 and $45.1 million in Q2 2023.